Q4 2025 Holdings
Filed 2026-02-11 | 20 holdings | $117.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Plains GP Hldgs L P(PAGPEUR) | LTD PARTNR INT A | 72651A207 | $24.4M | 1,272,360 | 20.8% |
| Achieve Life Sciences Inc(ACHV) | COM | 004468500 | $18.8M | 3,786,425 | 16.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $12.3M | 740,918 | 10.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $8.8M | 282,531 | 7.5% |
| Milestone Pharmaceuticals(MIST) | COM | 59935V107 | $8.3M | 4,118,321 | 7.1% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $6.3M | 666,666 | 5.4% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.9M | 861,778 | 5.1% |
| Inventiva SA(IVA) | ADS | 46124U107 | $4.7M | 1,000,000 | 4.0% |
| Delcath Systems Inc(DCTH) | COM NEW | 24661P807 | $4.4M | 438,509 | 3.8% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $4.4M | 830,780 | 3.7% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $4.2M | 154,300 | 3.6% |
| Nektar Therapeutics(NKTR) | COM NEW | 640268306 | $3.5M | 82,822 | 3.0% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $3.5M | 172,839 | 2.9% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $2.4M | 652,881 | 2.1% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $1.7M | 116,896 | 1.4% |
| Athira Pharma Inc(LONA) | COM | 04746L203 | $1.1M | 149,279 | 1.0% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $945.4K | 59,085 | 0.8% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $609.1K | 46,408 | 0.5% |
| Zevra Therapeutics Inc(ZVRA) | COM NEW | 488445206 | $570.6K | 63,683 | 0.5% |
| Kalaris Therapeutics Inc(KLRS) | COM | 482929106 | $354.9K | 42,053 | 0.3% |